ArticleBMC public health2026
Association of nocturnal lifestyle with overweight and obesity: a cross-sectional study based on SHOOW (Shanghai Overweight/Obesity and Wellness Study) cohort.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study aims to examine the associations between nocturnal lifestyle and overweight/obesity, especially central obesity. While most previous studies have examined individual nocturnal lifestyle factors separately, this study simultaneously evaluates three nocturnal lifestyle behaviors (weekly midnight snack frequency, bedtime, and sleep duration) in a clinical sample of overweight and obese adults, with a specific focus on central obesity indicators.
methodsThe study was based on clinical data of 1295 overweight and obese patients collected from a weight management outpatient clinic. We analyzed the associations between weekly midnight snack frequency, bedtime, sleep duration and obesity-related indicators.
resultsFemale patients accounted for 69.19% (896 cases) and male patients accounted for 30.81% (399 cases). Young and middle-aged adults (18-49 years old) constituted the largest proportion, reaching 91.51%. In terms of weekly midnight snack frequency, 58.92% of patients (763 cases) did not consume midnight snacks, 29.96% (388 cases) consumed midnight snacks 1-3 times per week, and 11.12% (144 cases) consumed midnight snacks 4-7 times per week. The largest group of patients (786 cases, 60.70%) went to bed between 22:00 and 24:00, while 409 patients (31.58%) fell asleep between 24:00 and 2:00. Most patients (1111 cases, 85.79%) had a nocturnal sleep duration of 4-8 h. Univariate linear regression analysis showed that weekly midnight snack frequency (4-7 times/week) was significantly positively associated with body mass index (BMI, P = 0.017) and waist circumference (WC, P = 0.003); weekly midnight snack frequency (1-3 times/week) was significantly positively associated with waist-to-hip ratio (WHR, P = 0.009). Compared with the 22:00-24:00 bedtime group, the after 2:00 group was significantly associated with all obesity indicators. The 24:00-2:00 group was significantly associated with all obesity indicators except body fat percentage (BFP). Concerning sleep duration, compared with the 4-8 h group, the > 8 h group was significantly associated with higher BMI (P = 0.002), neck circumference (NC, P = 0.008), WC (P = 0.003), WHR (P = 0.046) and upper arm circumference (UAC, P = 0.008). Multivariate linear regression analysis further confirmed that WC and WHR was jointly associated with weekly midnight snack frequency, bedtime and sleep duration.
conclusionNocturnal lifestyle was mainly associated with central obesity indicators, and adjustment of nocturnal lifestyle habits may be a consideration for central obesity prevention efforts.
Indexed as
Identifiers
42919195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.